
Bryan Y. Lee
Examiner (ID: 11209, Phone: (571)270-5606 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | IWPI, 2445, 2615 |
| Total Applications | 446 |
| Issued Applications | 316 |
| Pending Applications | 28 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7692221
[patent_doc_number] => 20070231812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Method of Screening Antidiabetic Agents'
[patent_app_type] => utility
[patent_app_number] => 11/587959
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8700
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587959 | Method of Screening Antidiabetic Agents | Apr 26, 2005 | Abandoned |
Array
(
[id] => 806898
[patent_doc_number] => 07420099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => 'Transgenic animals and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/111310
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 23
[patent_no_of_words] => 28516
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/420/07420099.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111310 | Transgenic animals and uses thereof | Apr 20, 2005 | Issued |
Array
(
[id] => 4799107
[patent_doc_number] => 20080010693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Human coagulation factor VII polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/111663
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19527
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20080010693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111663
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111663 | Human coagulation factor VII polypeptides | Apr 20, 2005 | Abandoned |
Array
(
[id] => 7220603
[patent_doc_number] => 20050260733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Proteases and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/106623
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18058
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260733.pdf
[firstpage_image] =>[orig_patent_app_number] => 11106623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/106623 | Proteases and uses thereof | Apr 14, 2005 | Abandoned |
Array
(
[id] => 5903129
[patent_doc_number] => 20060046243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Method for vitrification of mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 11/105918
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7923
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046243.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105918
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105918 | Method for vitrification of mammalian cells | Apr 13, 2005 | Abandoned |
Array
(
[id] => 6925373
[patent_doc_number] => 20050238628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Methods for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/100817
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16843
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238628.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100817 | Methods for treating cancer | Apr 6, 2005 | Abandoned |
Array
(
[id] => 4820669
[patent_doc_number] => 20080226704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Method of Producing Coated Fine Particles'
[patent_app_type] => utility
[patent_app_number] => 10/593723
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13529
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593723 | Method of Producing Coated Fine Particles | Mar 22, 2005 | Abandoned |
Array
(
[id] => 5639158
[patent_doc_number] => 20060070132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Methods for producing proteins using silkworm middle silk gland-specific gene expression system'
[patent_app_type] => utility
[patent_app_number] => 11/085838
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8231
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20060070132.pdf
[firstpage_image] =>[orig_patent_app_number] => 11085838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/085838 | Methods for producing proteins using silkworm middle silk gland-specific gene expression system | Mar 20, 2005 | Issued |
Array
(
[id] => 7136659
[patent_doc_number] => 20050181422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Process for high throughput screening of CpG-based immuno-agonist/antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/084777
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 51332
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084777
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084777 | Process for high throughput screening of CpG-based immuno-agonist/antagonist | Mar 17, 2005 | Issued |
Array
(
[id] => 7220134
[patent_doc_number] => 20050260679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Reducing the risk of human anti-human antibodies through V gene manipulation'
[patent_app_type] => utility
[patent_app_number] => 11/084554
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 81
[patent_no_of_words] => 39559
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084554 | Reducing the risk of human anti-human antibodies through V gene manipulation | Mar 16, 2005 | Abandoned |
Array
(
[id] => 5084920
[patent_doc_number] => 20070274971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Method of Proliferating Precursor Cells'
[patent_app_type] => utility
[patent_app_number] => 10/591741
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18281
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20070274971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591741
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591741 | Method of Proliferating Precursor Cells | Mar 3, 2005 | Abandoned |
Array
(
[id] => 5912916
[patent_doc_number] => 20060127978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Nucleic acid recombination method, host cell and expression vector'
[patent_app_type] => utility
[patent_app_number] => 11/071331
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13676
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127978.pdf
[firstpage_image] =>[orig_patent_app_number] => 11071331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/071331 | Nucleic acid recombination method, host cell and expression vector | Mar 3, 2005 | Abandoned |
Array
(
[id] => 6947185
[patent_doc_number] => 20050198699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Knockin non-human animal and tissue-specific MnSOD knockout non-human animal'
[patent_app_type] => utility
[patent_app_number] => 11/051177
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4366
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20050198699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051177
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051177 | Knockin non-human animal and tissue-specific MnSOD knockout non-human animal | Feb 3, 2005 | Abandoned |
Array
(
[id] => 278121
[patent_doc_number] => 07557197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-07
[patent_title] => 'Human soluble neuropilin-1 primary polyadenylation signal and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/046219
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14528
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/557/07557197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11046219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/046219 | Human soluble neuropilin-1 primary polyadenylation signal and uses thereof | Jan 27, 2005 | Issued |
Array
(
[id] => 4965312
[patent_doc_number] => 20080108132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Kit for Immobilizing Organic Substance, Organic Substance-Immobilized Structure, and Manufacturing Methods Therefor'
[patent_app_type] => utility
[patent_app_number] => 10/555383
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23757
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555383 | Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor | Jan 24, 2005 | Issued |
Array
(
[id] => 5774673
[patent_doc_number] => 20050268348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Mouse model for psoriasis and psoriatic arthritis'
[patent_app_type] => utility
[patent_app_number] => 11/038387
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6281
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20050268348.pdf
[firstpage_image] =>[orig_patent_app_number] => 11038387
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/038387 | Mouse model for psoriasis and psoriatic arthritis | Jan 20, 2005 | Issued |
Array
(
[id] => 322630
[patent_doc_number] => 07517863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide'
[patent_app_type] => utility
[patent_app_number] => 11/034682
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30826
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517863.pdf
[firstpage_image] =>[orig_patent_app_number] => 11034682
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/034682 | Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide | Jan 12, 2005 | Issued |
Array
(
[id] => 43332
[patent_doc_number] => 07776586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Method for isolating cells from mammary secretion'
[patent_app_type] => utility
[patent_app_number] => 10/584002
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 5395
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584002 | Method for isolating cells from mammary secretion | Dec 14, 2004 | Issued |
Array
(
[id] => 5842160
[patent_doc_number] => 20060121004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin'
[patent_app_type] => utility
[patent_app_number] => 11/006055
[patent_app_country] => US
[patent_app_date] => 2004-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16458
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121004.pdf
[firstpage_image] =>[orig_patent_app_number] => 11006055
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/006055 | Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin | Dec 6, 2004 | Abandoned |
Array
(
[id] => 860108
[patent_doc_number] => 07371539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-13
[patent_title] => 'Targeted polypeptide degradation'
[patent_app_type] => utility
[patent_app_number] => 11/003103
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11617
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371539.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003103
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003103 | Targeted polypeptide degradation | Dec 2, 2004 | Issued |